Director Biostatistics (Oncology)
BioNTech
Summary
As Director of Biostatistics you will represent Statistics in all assigned cross-functional clinical study teams and other projects and hold yourself accountable for all statistical aspects. You will serve as the biostatistics lead core team member for all assigned programs and provide statistical input into clinical development plans, clinical study protocols, clinical study reports, regulatory submission documents, and publications ensuring accurate deliverables.
Job description
About the Role
As Director of Biostatistics you will represent Statistics in all assigned cross-functional clinical study teams and other projects and hold yourself accountable for all statistical aspects. You will serve as the biostatistics lead core team member for all assigned programs and provide statistical input into clinical development plans, clinical study protocols, clinical study reports, regulatory submission documents, and publications ensuring accurate deliverables.
Your Contribution
- Work as part of a collaborative, cross-functional team with members from other disciplines
- Perform and/or verify sample size calculations
- Lead development of statistical analysis plans and TLFs, perform statistical analyses and validate analysis results
- Participate in planning for health authority meetings, development of associated documents, and the preparation of associated responses
- Oversee outsourced statistical CRO activities and deliverables ensuring highest quality and in a timely manner
- Support and participate in the development of departmental strategies, and cross functional initiatives on standards/infrastructures/processes
- Assumes possible line management responsibilities of junior staff and is responsible for recruiting, developing, and retaining talent
- Provide guidance to Statistical Programmers on SDTM/ADaM and TLFs specifications development and programming
- Provide input to database requirements and work closely with Clinical Data Manager to ensure data quality standards are met
A Good Match
- PhD or Masters in (Bio)Statistics, Mathematics or equivalent
- Minimum 10 years (13 years for masters) in the pharmaceutical industry and/or CRO
- At least 5 years of work/leadership experience, overseeing statistics staff (internal as well as outsourced) and in representing Biostatistics in a matrix organization and in a multidisciplinary team
- Experiences in planning, conducting and analyses of oncology or infectious diseases trials from phase I-IV, including scientific publications
- Experience in leading to health authority questions (FDA, EMA) and in leadings statistics on regulatory submissions, including developing ISE/ISS packages
- Very good knowledge and experience of clinical development, study designs, advanced statistical methods (adaptive design and/or Bayesian is a Plus), regulatory guidelines (ICH, FDA, EMA)
- Very good knowledge of statistical analysis software (SAS or R) and sample size calculation software (e.g., EAST and/or NQuery)
- Deep understanding of special topics like Diagnostics, Biomarker, PK/PD, PRO, RWE, is a plus
- Excellent analytical skills and ability to analyze complex issues to develop relevant and realistic plans, programs, recommendations, risk mitigation strategies, and the ability to communicate them to cross functional colleagues
- Strong drive for achieving high quality working results in a timely manner, while always safeguarding ethical standards in work and behaviors
- Excellent communication skills: the ability to express complex analysis in clear language; an excellent command of English written spoken
Requirements
- PhD or Masters in (Bio)Statistics, Mathematics or equivalent
- Minimum 10 years (13 years for masters) in the pharmaceutical industry and/or CRO
- At least 5 years of work/leadership experience overseeing statistics staff (internal and outsourced)
- Experience representing Biostatistics in a matrix organization and multidisciplinary team
- Experience in planning, conducting and analyses of oncology or infectious diseases trials from phase I-IV
- Experience with scientific publications
- Experience leading health authority questions (FDA, EMA)
- Experience leading statistics on regulatory submissions, including ISE/ISS packages
- Very good knowledge of clinical development and study designs
- Knowledge of advanced statistical methods (adaptive design and/or Bayesian is a plus)
- Knowledge of regulatory guidelines (ICH, FDA, EMA)
- Very good knowledge of statistical analysis software (SAS or R)
- Knowledge of sample size calculation software (e.g., EAST and/or NQuery)
- Deep understanding of Diagnostics, Biomarker, PK/PD, PRO, RWE is a plus
- Excellent analytical skills
- Excellent communication skills
- Excellent command of English written and spoken
Benefits
- Annual Bonus
- Equity
Company overview
BioNTech SE is a pioneering German multinational biotechnology company headquartered in Mainz, Germany, that specializes in developing innovative immunotherapies and vaccines for cancer and infectious diseases. Founded in 2008 by scientists Uğur Şahin, Özlem Türeci, and Christoph Huber, the company gained global recognition for co-developing the first approved mRNA-based COVID-19 vaccine with Pfizer. BioNTech's core expertise lies in mRNA technology, which it has been researching for over 15 years, with applications spanning individualized cancer medicine, infectious disease prevention, and novel therapeutic approaches. The company operates a diversified portfolio including mRNA cancer immunotherapies, next-generation immunomodulators, targeted therapies, and antibody-drug conjugates. With approximately 6,800 employees across more than 20 global sites, BioNTech maintains a strong focus on oncology, advancing multiple late-stage clinical programs while expanding its infectious disease pipeline to address conditions like malaria, tuberculosis, and mpox. The company's strategic acquisitions, including InstaDeep for AI capabilities and CureVac for mRNA expertise, further strengthen its position as a leader in next-generation biopharmaceutical innovation.